United States · Medical Device startup

Hemosphere

Hemosphere is a commercial medical device company specialized in vascular access for patients on dialysis.

Funding reportedLast round: Series A

Medical DeviceKennesaw, United States

What company datasets say Hemosphere raised

Funding, as reported

Reported in all$9.3Min dollars
Rounds1
Last roundSeries A
Last round dateApr 2010
Investors listed7

Founders and team

From Hemosphere's own website and the SEC filings it signed: 12 on the team.

  • Martha G. AronsonPresident and Chief Executive Officer
  • John HallExecutive Vice President, Global Research & Development
  • Pete DankwerthExecutive Vice President, Global Enterprise Excellence
  • Sheri LewisExecutive Vice President, Global Operations
  • Adam SmithChief Commercial Officer
  • Brian G. LloydChief Legal Officer and Corporate Secretary
  • Jason TreftChief Information Officer
  • John KnorppChief Regulatory Affairs Officer
  • Mike VoigtChief Human Resources Officer
  • Raul ParraChief Financial Officer
  • Doris S. EngibousExecutive Officer, Directori
  • Susan HorvathExecutive Officeri

On the board, as filediDavid SchulteEdson W. SpencerJonathan OsgoodMitchell W. DannTara ButlerWilliam S. Trainor

AdvisersNeil Peterson

On a portfolio page

Investors who name them

Each firm lists Hemosphere on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

How it ended, so far

Exit

ExitBuyerPriceWhen
AcquiredCryoLife$22MMay 2012

Medical Device in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Hemosphere in front of investors. Or tell us what we have wrong.